NASDAQ:KYNB | Free Cash Flow | KYNTRA BIO, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$13.89M$0.00-$13.89M
2025-12-31-$18.33M$0.00-$18.33M
2025-03-31$2.72M$16,000.00$2.7M58.27%
2024-12-31-$30.47M$141,000.00-$30.61M-170.21%
2024-03-31-$59.29M$29,000.00-$59.32M
2023-12-31-$18.32M$251,000.00-$18.57M
2023-03-31-$101.59M$591,000.00-$102.18M
2022-12-31-$52.51M$333,000.00-$52.85M
2022-03-31-$8.48M$1.64M-$10.11M
2021-12-31-$54.96M$1.4M-$56.36M
2021-03-31-$44.98M$518,000.00-$45.5M
2020-12-31-$7.23M$2.39M-$9.62M
2020-03-31-$59.49M$459,000.00-$59.95M
2019-12-31-$45.05M$1.75M-$46.8M
2019-03-31$22.48M$483,000.00$22M
2018-12-31-$17.47M$3.17M-$20.63M-98.47%
2018-03-31-$31.96M$1.84M-$33.8M
2017-12-31-$1.19M$3.51M-$4.69M
2017-03-31-$27.14M$636,000.00-$27.77M
2016-12-31-$18.55M$146,000.00-$18.69M
2016-03-31-$17.26M$898,000.00-$18.16M
2015-12-31-$39.3M$309,000.00-$39.61M
2015-03-31-$42.19M$448,000.00-$42.64M
2014-12-31-$23.77M$2.58M-$26.34M
2014-03-31-$15.52M$2.33M-$17.85M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$4.77M$38,000.00-$4.81M-2.62%
2024-12-31-$138M$266,000.00-$138.27M
2023-12-31-$315.02M$2.52M-$317.54M
2022-12-31-$145.93M$3.74M-$149.67M
2021-12-31-$82.23M$5.19M-$87.42M
2020-12-31$81.6M$3.99M$77.61M
2019-12-31-$78.71M$5.76M-$84.47M
2018-12-31-$76.14M$8.02M-$84.16M
2017-12-31-$66.51M$8.5M-$75.01M
2016-12-31$7.11M$1.25M$5.86M
2015-12-31-$18.57M$1.98M-$20.55M
2014-12-31$22.41M$8.12M$14.3M
2013-12-31$25.92M$6.81M$19.11M